Corrigendum to “Apremilast prevent doxorubicin-induced apoptosis and inflammation in heart through inhibition of oxidative stress mediated activation of NF-κB signaling pathways” [Pharmacol. Rep. 70 (2018) 993–1000]
Titel:
Corrigendum to “Apremilast prevent doxorubicin-induced apoptosis and inflammation in heart through inhibition of oxidative stress mediated activation of NF-κB signaling pathways” [Pharmacol. Rep. 70 (2018) 993–1000]
Auteur:
Imam, Faisal Al-Harbi, Naif O. Al-Harbi, Mohammad Matar Ansari, Mushtaq Ahmad Al-Asmari, Abdullah F. Ansari, Mohd Nazam Al-Anazi, Wael A. Bahashwan, Saleh Almutairi, Mashal M. Alshammari, Musaad Khan, Mohammad Rashid Alsaad, Abdulaziz Mohammed Alotaibi, Moureq Rashed
Verschenen in:
Pharmacological reports
Paginering:
Jaargang 71 () nr. 6 pagina's 1227
Jaar:
2019
Inhoud:
Uitgever:
Institute of Pharmacology, Polish Academy of Sciences